Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $2.48 is 31.91% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 2.515||$ 5.86|
|Low:||$ 2.45||$ 1.88|
Company Description (as filed with the SEC)
We are a fully integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical needs, with a near-term clinical focus on inflammatory and fibrotic diseases. We have very experienced research and clinical development teams, and we leverage their skills to evaluate and develop various in-licensed products and potential drug candidates from our small molecule and biologics platforms. By retaining global commercial rights to our clinical product candidates, we believe we have the ability to develop these candidates ourselves while maintaining flexibility for commercial and licensing arrangements. Below is a brief description of our lead product candidates: · Inflammatory and Fibrotic Diseases. ... More ...